BMC Complementary Medicine and Therapies最新文献

筛选
英文 中文
Optimization of Phellinus hartigii extracts: Biological activities, and phenolic content analysis.
IF 3.3 2区 医学
BMC Complementary Medicine and Therapies Pub Date : 2025-03-25 DOI: 10.1186/s12906-025-04851-9
Orhan Ünal, Ayşenur Gürgen, Tetiana Krupodorova, Mustafa Sevindik, Şanlı Kabaktepe, Ilgaz Akata
{"title":"Optimization of Phellinus hartigii extracts: Biological activities, and phenolic content analysis.","authors":"Orhan Ünal, Ayşenur Gürgen, Tetiana Krupodorova, Mustafa Sevindik, Şanlı Kabaktepe, Ilgaz Akata","doi":"10.1186/s12906-025-04851-9","DOIUrl":"10.1186/s12906-025-04851-9","url":null,"abstract":"<p><strong>Background: </strong>Medicinal mushrooms are sources of natural substances with diverse biological functions. The study evaluated the biological activity of Phellinus hartigii (Allesch. & Schnabl) Pat. and optimized extraction conditions to the maximize its bioactive potential.</p><p><strong>Methods: </strong>Extraction was performed using a Soxhlet apparatus under varying conditions: temperatures (30, 50, and 70 °C), durations (1, 5.5, and 10 h), and ethanol/water ratios (0%, 50%, and 100%). Total antioxidant status (TAS) was analyzed across 17 experiments, and the optimal conditions were identified using response surface methodology (RSM). Extracts from optimal conditions were further analyzed for antioxidant capacity (Rel assay kits, DPPH, FRAP), anticholinesterase activity (acetyl- and butyrylcholinesterase inhibition), antiproliferative activity (A549 lung cancer cell line), total phenolic content (Folin-Ciocalteu method), and phenolic compound profile (LC-MS/MS).</p><p><strong>Results: </strong>Optimal extraction conditions were determined to be 48.22 ˚C, 9.04 h, and an ethanol/water ratio of 52.22%. The extract exhibited significant antiproliferative effects against the A549 lung cancer cells, with activity increasing in a concentration-dependent manner. The inhibition values (IC<sub>50</sub>) of acetylcholinesterase and butyrylcholinesterase were 21.29 ± 0.41 and 35.51 ± 0.53 μg/mL, respectively. The TPC (total phenolic content) value of the optimized extract was determined as 88.21 ± 1.50 mg/g, FRAP value as 137.81 ± 1.72 mg/g, DPPH value as 106.07 ± 2.44 mg/g, TOS (total oxidant status) value as 9.27 ± 0.06 µmol/L, TAS value as 4.98 ± 0.03 mmol/L and OSI (oxidative stress index) value as 0.19 ± 0.002. LC-MS/MS analysis identified nine phenolic compounds, with gallic acid and catechin hydrate as the most abundant.</p><p><strong>Conclusions: </strong>The extract of P. hartigii obtained under optimal conditions demonstrated substantial antioxidant, anticholinesterase, and antiproliferative activities, highlighting its therapeutic potential.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"113"},"PeriodicalIF":3.3,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934515/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143708484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health information-seeking behavior among users of traditional, complementary and integrative medicine (TCIM).
IF 3.3 2区 医学
BMC Complementary Medicine and Therapies Pub Date : 2025-03-21 DOI: 10.1186/s12906-025-04843-9
Miriam Trübner, Alexander Patzina, Judith Lehmann, Benno Brinkhaus, Christian S Kessler, Rasmus Hoffmann
{"title":"Health information-seeking behavior among users of traditional, complementary and integrative medicine (TCIM).","authors":"Miriam Trübner, Alexander Patzina, Judith Lehmann, Benno Brinkhaus, Christian S Kessler, Rasmus Hoffmann","doi":"10.1186/s12906-025-04843-9","DOIUrl":"10.1186/s12906-025-04843-9","url":null,"abstract":"<p><strong>Background: </strong>The use of traditional, complementary, and integrative medicine (TCIM) is widespread among the German population and driven by various motives, including both supplementing and avoiding treatments with conventional medicine. The aim of this article is to examine how these motives relate to different health information-seeking behaviors.</p><p><strong>Methods: </strong>The study uses regression analysis based on data from a German online access panel, which explored the use and acceptance of TCIM in Germany in 2022. From this study, we use information on 1,696 individuals (aged 18-75 years) who vary in their motives for using TCIM (subjective statements on five-point Likert scales) and have used TCIM to treat health problems.</p><p><strong>Results: </strong>Overall, TCIM is considered more a health-promoting measure than it is driven by aversion towards conventional medicine. Our analysis of information-seeking behavior for certain therapeutic procedures reveals that, as respondents' propensity to use TCIM as a health-promoting measure rises, they are more likely to perceive themselves as being influenced by scientific studies (AME: 0.04, p = 0.004), personal advice (AME: 0.09, p = 0.000), and their social circle's experiences (AME: 0.08, p = 0.000). In contrast, respondents who use TCIM more due to aversion to conventional medicine are less likely to perceive themselves as being influenced by scientific studies (AME: -0.04, p = 0.004) and doctors (AME: -0.07, p = 0.000). When analyzing respondents' most important medical information source, our results reveal that the more individuals indicate using TCIM out of aversion, the more likely they are to consider (online) media outlets their most important medical resource (AME: 0.05, p = 0.000), while the likelihood of considering medical professionals most important decreases (AME -0.06, p = 0.000).</p><p><strong>Conclusion: </strong>Motives behind TCIM use vary and correspond to differences in individuals' health information-seeking behavior. Beyond these motive-related differences, TCIM users value sources of health information other than their medical practitioners. This calls for an intensification of TCIM training among medical professionals to provide high-quality consultation and the creation of reputable online portals to ensure the provision of trustworthy information about TCIM.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"111"},"PeriodicalIF":3.3,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11927221/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143676663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Based on network pharmacology and molecular docking technology to explore the pharmacodynamic components and mechanism of Gynostemmae Pentaphylli Herba reversing Cervical intraepithelial neoplasia.
IF 3.3 2区 医学
BMC Complementary Medicine and Therapies Pub Date : 2025-03-21 DOI: 10.1186/s12906-025-04841-x
Huifang Wang, Yiling Chen, Tingting Lin
{"title":"Based on network pharmacology and molecular docking technology to explore the pharmacodynamic components and mechanism of Gynostemmae Pentaphylli Herba reversing Cervical intraepithelial neoplasia.","authors":"Huifang Wang, Yiling Chen, Tingting Lin","doi":"10.1186/s12906-025-04841-x","DOIUrl":"10.1186/s12906-025-04841-x","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate the pharmacodynamic components of Gynostemmae Pentaphylli Herba reversing Cervical intraepithelial neoplasia (CIN) were investigated by network pharmacology, and the mechanism of action was analyzed by molecular docking technology.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The effective components and targets of Gynostemmae Pentaphylli Herba and the disease target of CIN were searched in TCMSP, Pubchem, Swiss Target Prediction, GenCards, WebGestalt, and STRING. Based on the above data and the Cytoscape software, we mapped the protein-protein interaction (PPI) co-expression network. The mechanism of Gynostemmae Pentaphylli Herba CIN treatment was identified from the enrichment analysis perspective. We performed molecular docking on the AutoDock. Finally, we carried out cell experiments for verification.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Eighty-five targets matching the active ingredients of Gynostemmae Pentaphylli Herba, and 2512 CIN-related action targets were obtained. The nodal degree values of five components and the target of Gynostemmae Pentaphylli Herba in the top 5 were IL6, IL1β, TNF, TP53, and PTGS2. There were 52 intersection targets of the effective active ingredient of Gynostemmae Pentaphylli Herba and CIN. The PPI network map suggested that the main active ingredient MOL000098 (Quercetin) had the most targets (40), followed by MOL000351 (Rhamnazin) (17). Gene Ontology (GO) analysis yielded the regulation of transcription from RNA polymerase II promoter, cytoplasm, extracellular space and enzyme binding, zinc ion binding, etc. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway identified 114 signaling pathways. These pathways were mainly enriched in positive regulation of transcription from RNA polymerase II promoter, positive regulation of gene expression, cytoplasm, extracellular space, enzyme binding, zinc ion binding, Pathways in cancer, Fluid shear stress and atherosclerosis, etc. The binding energies of IL6, IL1β, TNF, TP53, and PTGS2 with Quercetin, Rhamnazin, Gypenoside XXVII_qt and Gypenoside XXVIII_qt were all less than -5 kcal·mol&lt;sup&gt;-1&lt;/sup&gt;, respectively. The messenger ribonucleic acid (mRNA) expressions of IL6, IL1β, TNF, and PTGS2 in the experimental group were higher (t = 105.700, 32.450, 18.190, and 100.400, all P &lt; 0.001), and the mRNA expressions of TP53 was lower compared with the control group (t = 8.362, all P = 0.001).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Gynostemmae Pentaphylli Herba may reverse CIN through targeted action of Quercetin, Rhamnazin, and gypenosides, as well as various pathways. Our study preliminarily explored the pharmacodynamic components and mechanism of the reversal of CIN by Gynostemmae Pentaphylli Herba and verified the possible mechanism of action through cell and molecular biology experiments to understand the pharmacological mechanism of Gynostemmae Pentaphylli Herba in CIN and provide data reference for new drugs and clinical trials research, whi","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"112"},"PeriodicalIF":3.3,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11927119/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143676711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of MediYoga on sleep-quality, blood pressure and quality of life among older people with hypertension: study protocol of a pragmatic randomized controlled trial. MediYoga对患有高血压的老年人的睡眠质量、血压和生活质量的影响:实用随机对照试验的研究方案。
IF 3.3 2区 医学
BMC Complementary Medicine and Therapies Pub Date : 2025-03-20 DOI: 10.1186/s12906-025-04846-6
Signe Stelling Risom, Katrine Vollbrecht Amdi, Maria Wahlström, Trine Bernholdt Rasmussen, Suresh Sharma, Zarina Nahar Kabir, Hanne Konradsen
{"title":"The effect of MediYoga on sleep-quality, blood pressure and quality of life among older people with hypertension: study protocol of a pragmatic randomized controlled trial.","authors":"Signe Stelling Risom, Katrine Vollbrecht Amdi, Maria Wahlström, Trine Bernholdt Rasmussen, Suresh Sharma, Zarina Nahar Kabir, Hanne Konradsen","doi":"10.1186/s12906-025-04846-6","DOIUrl":"10.1186/s12906-025-04846-6","url":null,"abstract":"<p><strong>Background: </strong>High blood pressure (BP) is a common condition that is estimated to soon affect one third of the worlds' population. Poor subjective sleep quality is shown to be associated with an elevated risk of high BP, though it is a risk factor that can be modified. Yoga can be used as a complementary therapy to lower BP, but more knowledge on duration and intensity are needed. The overall aim is to test the effect of an online yoga intervention as a complementary therapy. The objectives are to: (1) Test whether online yoga can improve sleep quality, health related quality of life, and lower BP. (2) To explore and describe the implementation of online yoga and the participants' experiences and perspectives on the intervention in a process evaluation.</p><p><strong>Methods: </strong>A pragmatic randomized controlled trial will be conducted. The study is described in accordance with the SPIRIT guidelines (Standard Protocol Items: Recommendations for Interventional Trials) and results will be reported following the CONSORT (CONsolidated Standards Of Reporting Trials) guidelines for pragmatic trials. The study is designed as a three arm, randomized superiority trial.</p><p><strong>Inclusion criteria: </strong>≥65 years old, diagnosed with high BP, speaking and reading Danish, able to consent, no comorbidity that restricts them from participating in the intervention, and daily access to a smartphone or tablet. Participants will be randomly assigned to (i) control group which will be receiving treatment as usual (TAU), or to one of two intervention-groups (ii) performing yoga twice a week for 20 min (20 MIN) or (iii) 40 min (40 MIN) for a total of 10 weeks in addition to TAU. The primary outcome is sleep quality measured by the Pittsburg Sleep Quality Index and secondary outcomes include health related quality of life and BP. Analysis will present differences between groups and be carried out by a statistician blinded to group allocation.</p><p><strong>Discussion: </strong>The study is grounded in the urgent need to address high BP since pharmacological interventions remain the primary treatment modality, the exploration of non-pharmacological strategies, such as yoga, offers a promising avenue for enhancing patient outcomes in a holistic manner.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov ID NCT06553820. Protocol version 1. 13th November 2024.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"109"},"PeriodicalIF":3.3,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11927251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of single or multi-period use of transcutaneous acupoint electrical stimulation on postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery: a prospective randomized double-blind trial.
IF 3.3 2区 医学
BMC Complementary Medicine and Therapies Pub Date : 2025-03-20 DOI: 10.1186/s12906-025-04847-5
Li-Dan Jin, Wan Lei, Jing Xu, Li Xing, Yao-Hua Shen, Su-Feng Lin, Yu-Fei Chen, Ting-Ting He, Xi-Yang Wang
{"title":"Effect of single or multi-period use of transcutaneous acupoint electrical stimulation on postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery: a prospective randomized double-blind trial.","authors":"Li-Dan Jin, Wan Lei, Jing Xu, Li Xing, Yao-Hua Shen, Su-Feng Lin, Yu-Fei Chen, Ting-Ting He, Xi-Yang Wang","doi":"10.1186/s12906-025-04847-5","DOIUrl":"10.1186/s12906-025-04847-5","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the efficacy of different periods for the prevention of postoperative nausea and vomiting (PONV) in patients undergoing gynecological laparoscopy with transcutaneous electrical acupoint stimulation (TEAS).</p><p><strong>Design: </strong>Prospective, randomized, double-blind trial.</p><p><strong>Setting: </strong>An academic medical canter specializing in the care of women and children.</p><p><strong>Population or sample: </strong>A total of 120 women were enrolled.</p><p><strong>Methods: </strong>Patients were randomly allocated to three groups: a single-period TEAS group (Group S, n = 40), a multi-period TEAS group (Group M, n = 40) and a non-stimulation control group (Group C, n = 40). TEAS was applied at specific acupuncture points preoperatively and postoperatively.</p><p><strong>Main outcome measures: </strong>The primary outcome was the incidence and severity of PONV during the 48 h after surgery and the secondary outcomes included pain, early recovery after surgery, and complication.</p><p><strong>Results: </strong>Within postoperative 0-2 h, 4-12 h, group M had less frequency and lower scores for nausea compared with group C and group S had only less frequency of nausea compared with group C at 4-12 h postoperatively. The frequency and severity of vomiting for group M were less than group S in the postoperative 2-4 h. Group M mitigated pain and reduced the rescue antiemetic compared to group S.</p><p><strong>Conclusion: </strong>Multiple-period TEAS provides greater efficacy and a longer duration of action than single-period TEAS. It effectively reduces PONV in patients undergoing gynecological laparoscopic surgery which could be a new option in multimodal prophylactic antiemetic regimes for perioperative undergoing gynecological laparoscopic surgery.</p><p><strong>Trial registration: </strong>Chinese Clinical Trials Registry, No. ChiCTR2200065802, Registered 15/11/2022. https//www.chictr.org.cn/bin/project/edit? pid=175,377.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"110"},"PeriodicalIF":3.3,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11927246/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing a deep learning model for the automated monitoring of acupuncture needle insertion: enhancing safety in traditional acupuncture practices.
IF 3.3 2区 医学
BMC Complementary Medicine and Therapies Pub Date : 2025-03-18 DOI: 10.1186/s12906-025-04853-7
Shun-Ku Lin, Chien-Kun Su, Melnard Rome C Mercado, Syu-Jyun Peng
{"title":"Developing a deep learning model for the automated monitoring of acupuncture needle insertion: enhancing safety in traditional acupuncture practices.","authors":"Shun-Ku Lin, Chien-Kun Su, Melnard Rome C Mercado, Syu-Jyun Peng","doi":"10.1186/s12906-025-04853-7","DOIUrl":"10.1186/s12906-025-04853-7","url":null,"abstract":"<p><strong>Background: </strong>Acupuncture is a widely practiced traditional therapy, yet safety concerns, particularly needle breakage and retention, remain critical issues that can lead to complications such as infections, organ injury, or chronic pain. This study aimed to develop a deep learning model to monitor acupuncture needle insertion, detect instances of needle breakage, and prevent needle retention, ultimately improving patient safety and treatment outcomes.</p><p><strong>Methods: </strong>A deep learning model based on the YOLOv8 architecture was trained using a dataset comprising 192 images from a commercial image library and 73 clinical images captured during real-world acupuncture sessions. Images were preprocessed through cropping and annotation, and augmented to enhance model generalizability. Five-fold cross-validation was employed to ensure robust performance. Model evaluation metrics included precision, recall, F1 score, and mean average precision (mAP) at Intersection over Union (IoU) thresholds of 50% (mAP@50) and 50-95% (mAP@50-95).</p><p><strong>Results: </strong>The model demonstrated strong performance, achieving an average precision of 88.0% and a recall of 82.9%. The mean average precision was 88.6% at mAP@50 and 62.9% at mAP@50-95, indicating high reliability in detecting acupuncture needles across diverse scenarios. These results highlight the potential of the model to enhance clinical safety by minimizing risks associated with needle breakage and retention, regardless of practitioner experience or patient demographics.</p><p><strong>Conclusions: </strong>The proposed YOLOv8-based deep learning model offers a reliable method for real-time needle monitoring in acupuncture. Its integration into clinical workflows can improve safety and efficiency, especially in underserved regions or settings with less experienced practitioners. Future research should validate the model with larger, more diverse datasets and explore its application in various healthcare settings.</p><p><strong>Trial registration: </strong>Not applicable; this study did not involve a healthcare intervention requiring registration. Data collection adhered to ethical standards with institutional approval (TCHIRB-11310004).</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"108"},"PeriodicalIF":3.3,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917098/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143656081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revealing the multi-target compounds of Sarcandra glabra identification and inhibition of novel target genes for the treatment of pancreatic cancer.
IF 3.3 2区 医学
BMC Complementary Medicine and Therapies Pub Date : 2025-03-17 DOI: 10.1186/s12906-025-04839-5
Xing Liu, Jianghong Ou
{"title":"Revealing the multi-target compounds of Sarcandra glabra identification and inhibition of novel target genes for the treatment of pancreatic cancer.","authors":"Xing Liu, Jianghong Ou","doi":"10.1186/s12906-025-04839-5","DOIUrl":"10.1186/s12906-025-04839-5","url":null,"abstract":"<p><strong>Background: </strong>S. glabra has been widely used to treat tumors in traditional Chinese medicine (TCM). However, the specific mechanism of action of S. glabra in pancreatic cancer remains unclear. In this study, network pharmacological analysis was used to identify the active components of S. glabra and their corresponding targets for the treatment of pancreatic cancer. Furthermore, molecular docking, molecular dynamic simulations, and in vitro experiments were performed to validate the findings.</p><p><strong>Methods: </strong>The active components of S. glabra and their corresponding targets for the treatment of pancreatic cancer were identified using the TCMSP database and a literature search. Differentially expressed genes were identified using data from the Gene Expression Omnibus (GEO) database, and their protein-protein interaction (PPI) network was constructed using the STRING platform. The target genes of S. glabra were further assessed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses in the R software. Subsequently, a protein-protein interaction (PPI) network and a composite target-pathway network were established. The target genes were subjected to survival and mutation analyses. Molecular docking and molecular dynamic simulations were used to validate the interaction between the hub target genes and S. glabra in vitro. In addition, cell viability and qRT-PCR verification of S. glabra against pancreatic cancer in vitro.</p><p><strong>Results: </strong>A total of 20 active components and 70 targets were identified. Based on the PPI network, CASP3, MMP9, CCND1, EGF, MMP2, CASP8, ERBB2, STAT1, and PPARG were identified as hub target genes. Enrichment analysis showed that S. glabra may primarily affect pathways such as p53 signaling, transcriptional dysregulation in cancer, proteoglycans in cancer, pancreatic cancer, and cell cycle. Molecular docking and molecular dynamic simulations indicated stable binding between anhydroicaritin-GSK3B and quercetin-PPARG. In vitro experiments demonstrated that treatment with S. glabra significantly inhibited the growth of PANC-1 cells and downregulated expression of GSK3B and PPARG (P < 0.05).</p><p><strong>Conclusion: </strong>This study demonstrates the potential of S. glabra, a herb in traditional Chinese medicine, for treating pancreatic cancer. The findings provide insights into the mechanism of action of the active ingredients of S. glabra, offering a strong theoretical foundation for its various clinical applications.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"106"},"PeriodicalIF":3.3,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11912788/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acceptability and feasibility of online delivery of chair-based yoga for older adults with multimorbidity - lessons from a process evaluation of the gentle years yoga trial.
IF 3.3 2区 医学
BMC Complementary Medicine and Therapies Pub Date : 2025-03-17 DOI: 10.1186/s12906-025-04838-6
Lesley Ward, Laura Bissell, Jenny Howsam, Garry A Tew, Laura Wiley, Fiona Rose, Camila Sofía, Maturana Palacios, Tim Rapley
{"title":"Acceptability and feasibility of online delivery of chair-based yoga for older adults with multimorbidity - lessons from a process evaluation of the gentle years yoga trial.","authors":"Lesley Ward, Laura Bissell, Jenny Howsam, Garry A Tew, Laura Wiley, Fiona Rose, Camila Sofía, Maturana Palacios, Tim Rapley","doi":"10.1186/s12906-025-04838-6","DOIUrl":"10.1186/s12906-025-04838-6","url":null,"abstract":"<p><strong>Background: </strong>Yoga is a safe, effective, and popular practice among older adults, and amenable to online delivery. The Gentle Years Yoga randomised controlled trial compared the impact of a chair-based yoga programme to usual care on the health-related quality of life of older adults with multimorbidity. This embedded, longitudinal process evaluation qualitatively explored experiences and acceptability of online delivery of the trial intervention.</p><p><strong>Methods: </strong>A subset of trial participants randomised to receive the 12-week online yoga programme, together with the trial yoga teachers, were purposively recruited to semi-structured interviews. Individual interviews were conducted via Zoom or telephone, audio-recorded, independently transcribed, and thematically analysed. Online observations were conducted of one class delivered by each teacher.</p><p><strong>Results: </strong>Eighteen yoga participants (66-91 years; 2-8 chronic health conditions) and nine teachers were interviewed once (N = 12) or twice (N = 15) from October 2020 to April 2022. Five themes predominated, common to both groups. (1) Accessibility. Reduced communication and engagement inherent to online delivery were mostly outweighed by its removal of access barriers and provision of anonymity and distraction-free environment. (2) Technology issues. While digital literacy was variable and a barrier for some, simplified access procedures and basic audiovisual instruction optimised class engagement. (3) Delivery adaptations. Key facilitation techniques included simple, repetitive instructions, increased demonstration, personalised communication, and visibility-enhancing clothing. (4) Safety. Concerns were minimal, and mostly related to restricted visual and positional information inherent to face-to-face classes. (5) Implications and implementations. Online delivery was considered viable and potentially appealing for anyone experiencing issues accessing face-to-face classes outside the home. Potential solutions to online attendance barriers included equipment loan schemes and digital learning courses using existing community-based infrastructures.</p><p><strong>Conclusions: </strong>Online chair-based yoga classes were feasible and acceptable to participants and teachers, and preferrable to face-to-face delivery by some. IT issues were minimal, and mainly resolvable through simple access processes and educational information. Accessibility advantages suggest online yoga may be suitable for a broad demographic, independent of age or health status. Establishing connections with existing health and community-based organisations presents a potential pathway for developing an equipment loan scheme to improve accessibility for those with financial access barriers.</p><p><strong>Trial registration: </strong>ISRCTN ISRCTN13567538. Registered 18 March 2019.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"107"},"PeriodicalIF":3.3,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11912673/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of garlic and stevia extract with aerobic exercise on hypothalamic leptin and ghrelin receptor mRNA expression and insulin resistance in obese rats.
IF 3.3 2区 医学
BMC Complementary Medicine and Therapies Pub Date : 2025-03-14 DOI: 10.1186/s12906-025-04756-7
Zohre Amirkhani, Armin Morteza Gholi, Sara Asghari, Danial Hakak, Mahdi Pouryousef, Behrooz Yahyaei, Sayyed-Javad Ziaolhagh
{"title":"The effect of garlic and stevia extract with aerobic exercise on hypothalamic leptin and ghrelin receptor mRNA expression and insulin resistance in obese rats.","authors":"Zohre Amirkhani, Armin Morteza Gholi, Sara Asghari, Danial Hakak, Mahdi Pouryousef, Behrooz Yahyaei, Sayyed-Javad Ziaolhagh","doi":"10.1186/s12906-025-04756-7","DOIUrl":"10.1186/s12906-025-04756-7","url":null,"abstract":"<p><strong>Background: </strong>Obesity has recently become the most prevalent diet-related disease worldwide. This study aimed to investigate the effects of aerobic exercise, stevia, and garlic extract on leptin and ghrelin receptor mRNA, as well as the interactions between insulin and glucose in relation to these genes.</p><p><strong>Methods: </strong>A total of 50 male Wistar rats were split into two groups: one group was fed regular rodent food, while the other was fed a high-fat diet for 12 weeks to induce obesity. The obese rats were then divided into six groups of five (N = 5) based on Lee's index: an obese control group (OC), obese treated with garlic, stevia (OGS), obese aerobic exercise (OE), obese garlic and aerobic exercise (OGE), Obese stevia and aerobic exercise (OSE), and a Normal weight group (NC). The exercise groups participated in a gradually increasing aerobic walking program, whereas the stevia and garlic groups received daily oral doses of their respective extracts. The expression of leptin and ghrelin receptor genes in the hypothalamus was measured using real-time PCR, and insulin resistance was calculated using the HOMA/IR formula. Statistical analysis was conducted using ANOVA, with a significance level set at P < 0.05.</p><p><strong>Results: </strong>The obese (O) rats experienced a significant increase in body weight compared with the control (C) rats (p = 0.013), whereas the treated rats showed no significant changes in weight. Leptin receptor mRNA levels were significantly lower in O rats than in C rats (p = 0.00), but increased significantly in the OS (p = 0.000) and OSE (p = 0.034) groups compared with obese rats. Ghrelin receptor mRNA levels were significantly higher in the O group than in the C group (p = 0.035), but decreased in all treatment groups, with the OE (p = 0.001), OGE (p = 0.001), and OSE (p = 0.004) groups showing the greatest reductions. Insulin resistance increased slightly in the O group compared with the C group (p = 0.112), but was lowest in the OS group among all groups (p = 0.018).</p><p><strong>Conclusions: </strong>Stevia significantly improved leptin and ghrelin receptor mRNA expression, glucose levels, and insulin resistance in obese rats, showing its potential as an effective dietary intervention for managing obesity.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"104"},"PeriodicalIF":3.3,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11907805/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143633584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemical composition, antioxidant, antimicrobial, and anticancer activities of Mahonia napaulensis DC. bark from Nepal. 尼泊尔 Mahonia napaulensis DC. 树皮的化学成分、抗氧化、抗菌和抗癌活性。
IF 3.3 2区 医学
BMC Complementary Medicine and Therapies Pub Date : 2025-03-14 DOI: 10.1186/s12906-025-04806-0
Rajib Kumar Shrestha, Satyabrata Nayak, Prabal Singh Maharjan, Bivek Pokharel, Gagan Deep Jhingan, Rana Pratap Singh, Neel Sarovar Bhavesh, Bhupal Govinda Shrestha
{"title":"Chemical composition, antioxidant, antimicrobial, and anticancer activities of Mahonia napaulensis DC. bark from Nepal.","authors":"Rajib Kumar Shrestha, Satyabrata Nayak, Prabal Singh Maharjan, Bivek Pokharel, Gagan Deep Jhingan, Rana Pratap Singh, Neel Sarovar Bhavesh, Bhupal Govinda Shrestha","doi":"10.1186/s12906-025-04806-0","DOIUrl":"10.1186/s12906-025-04806-0","url":null,"abstract":"<p><strong>Background: </strong>Cancer is one of the major health problems worldwide and medicinal plants constitute a common alternative for cancer treatment having no or fewer side effects. This study aimed to assess total phenolic (TPC) and flavonoid (TFC) contents, antioxidant, biological activities (especially antibacterial, antifungal, and anticancer), and chemical composition of methanol extract of M. napaulensis DC. bark (MNBM). This is the first study evaluating its anticancer activity and chemical composition by LC-MS/MS analysis.</p><p><strong>Methods: </strong>TPC, TFC, antioxidant, antimicrobial, and anticancer activities were determined by Folin-Ciocalteu, AlCl<sub>3</sub>, DPPH, Resazurin, and MTT assays, respectively. Its metabolite profiling was done by LC-MS/MS analysis. The statistical significance of differences between test groups was analyzed by a one-way ANOVA.</p><p><strong>Results: </strong>The preliminary phytochemical screening revealed the presence of various phytochemicals viz. alkaloids, steroids, glycosides, polyphenols, tannins, flavonoids, coumarins, terpenoids, and quinone. MNBM showed 38.00 ± 1.50 mg GAE g<sup>-1</sup> dry sample as TPC, 35.04 ± 4.87 mg QE g<sup>-1</sup> dry sample as TFC, and 212.97 μg/mL IC<sub>50</sub> value (P < 0.05) as moderate antioxidant activity. MNBM showed minimal inhibitory concentration (MIC) values of 100.22 mg/mL, 50.15 mg/mL, and 25.08 mg/mL against S. aureus, E. coli, and C. albicans, respectively as weak antimicrobial activity. It showed no antibacterial effect against B. cereus and P. aeruginosa at 120 mg/mL. The anticancer activity of MNBM was moderate against human lung cancer cells A549 (228.97 μg/mL IC<sub>50</sub> value) and human cervical cancer cells HeLa (367.72 µg/mL IC<sub>50</sub> value) (P < 0.05). The LC-MS/MS analysis reported the presence of different anticancer compounds viz. dihydroberberine, d-berbamine, (S)-glaucine, protopine, grosheimin, mycophenolic acid, berberine, alpha-linolenic acid, etc. CONCLUSIONS: MNBM showed dose-dependent moderate antioxidant, weak antibacterial, weak antifungal, and moderate anticancer activity due to the synergistic effect of different phytochemicals and anticancer compounds.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"105"},"PeriodicalIF":3.3,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11907818/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143633575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信